Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 106
interventional 39
Observational 62
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 11
Procedure 8
Device 5
Diagnostic Test 3
Other 3
Behavioral 1
Biological|Device|Procedure 1
Biological|Drug|Other 1
Biological|Drug|Procedure 1
Biological|Other 1
Drug|Other 1
Drug|Procedure 1
Genetic 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
France 9
United States 6
China 5
Czechia 3
Netherlands 2
Spain 2
Switzerland 2
Austria 1
Belgium|France|Germany|United Kingdom 1
Brazil 1
Canada 1
Denmark 1
Germany 1
Ireland|United Kingdom 1
Norway 1
Taiwan 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 26
2 3
3 2
4 1
6 1
7 1
9 1
10 1
14 2
80 1

Phase

Phase Study_Count
N/A 22
Phase 2 7
Phase 4 5
Phase 3 2
Early Phase 1 1
Phase 1 1
Phase 1/Phase 2 1

Number of Arms

Number_of_Arms Count_of_Studies
1 19
2 16
3 2
8 1
NA 1

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.3 Phase.4
Min. 6 10.0000 24 86 32.0000 142.00 50.0
1st Qu. 6 48.7500 24 86 120.0000 172.75 86.0
Median 6 64.5000 24 86 155.0000 203.50 120.0
Mean 6 250.7727 24 86 326.2857 203.50 135.4
3rd Qu. 6 215.0000 24 86 270.0000 234.25 200.0
Max. 6 2240.0000 24 86 1317.0000 265.00 221.0

Trial Group Type

group_type Group_Count
Experimental 29
Other 22
Active Comparator 10
No Intervention 4
NA 1

Intervention Model

intervention_model Study_Count
Single Group Assignment 23
Parallel Assignment 16

Primary Purpose

primary_purpose Study_Count
Treatment 17
Diagnostic 12
Screening 5
Device Feasibility 2
Other 2
Prevention 1

Observational Studies

Studies by Country

Country Study_Count
United States 23
China 10
Taiwan 7
France 4
Canada 3
Italy 3
Hong Kong 2
Korea, Republic of 2
Sweden 2
Belgium 1
Germany 1
India 1
Singapore 1
Spain 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 54
2 3
3 2
4 1
9 1
20 1

Enrollment Metrics

Measure Observational
Min 3.0000
1st Qu 52.2500
Median 100.0000
Mean 208.9516
3rd Qu 200.0000
Max 3125.0000

Observation Model

observational_model Study_Count
Cohort 35
Case-Only 15
Case-Control 6
Other 5
Case Control 1

Time Perspective

time_perspective Study_Count
Prospective 56
Retrospective 3
Cross-Sectional 2
Other 1

Registries

Studies by Country

Country Study_Count
China 2
Denmark 1
NA 1
United States 1

Sites per Study

Site_count Study_Count
1 5

Enrollment Metrics

Measure Registries
Min 71.0
1st Qu 80.0
Median 130.0
Mean 136.2
3rd Qu 200.0
Max 200.0

Registry Model

observational_model Study_Count
Cohort 4
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 5

Follow-up

target_duration Study_Count
5 Years 2
1 Day 1
2 Years 1
3 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03340844 Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors https://ClinicalTrials.gov/show/NCT03340844 Recruiting Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 2020-12-15
NCT03337347 Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients https://ClinicalTrials.gov/show/NCT03337347 Completed The Institute of Molecular and Translational Medicine, Czech Republic 2007-02-28
NCT03213041 Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer https://ClinicalTrials.gov/show/NCT03213041 Recruiting Northwestern University 2021-06-01
NCT03050866 Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs) https://ClinicalTrials.gov/show/NCT03050866 Recruiting Erasmus Medical Center 2019-09-30
NCT02941536 Correlation Between Circulating Tumor Cells and Brain Disease Control After Focal Radiotherapy for Metastases of Breast Cancer https://ClinicalTrials.gov/show/NCT02941536 Completed AC Camargo Cancer Center 2018-10-15
NCT02849041 Screening of Tobacco-induced Cancers by Low-dose CT-scanner and Identification of Circulating Tumor Cells https://ClinicalTrials.gov/show/NCT02849041 Recruiting Groupe Hospitalier Paris Saint Joseph 2020-07-23
NCT02808884 Cancer DNA Screening Pilot Study (CANDACE) https://ClinicalTrials.gov/show/NCT02808884 Active, not recruiting British Columbia Cancer Agency 2020-01-31
NCT02552394 J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts https://ClinicalTrials.gov/show/NCT02552394 Recruiting Weill Medical College of Cornell University 2021-12-31
NCT02453139 Exercise, Prostate Cancer and Circulating Tumour Cells https://ClinicalTrials.gov/show/NCT02453139 Completed University of Dublin, Trinity College 2017-06-30
NCT02372448 Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients https://ClinicalTrials.gov/show/NCT02372448 Active, not recruiting Centre Hospitalier Universitaire de Nice 2019-11-21
NCT02335151 CTC Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT02335151 Completed University of Zurich 2019-09-30
NCT02080650 Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) https://ClinicalTrials.gov/show/NCT02080650 Completed Duke University 2016-05-19
NCT02075606 Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients https://ClinicalTrials.gov/show/NCT02075606 Completed Ipsen 2017-06-30
NCT02072616 Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma. https://ClinicalTrials.gov/show/NCT02072616 Recruiting University Hospital, Rouen 2018-09-30
NCT02048540 Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell https://ClinicalTrials.gov/show/NCT02048540 Completed Chinese PLA General Hospital 2013-12-31
NCT02035813 DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs). https://ClinicalTrials.gov/show/NCT02035813 Recruiting University of Ulm 2020-12-31
NCT02032368 Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence https://ClinicalTrials.gov/show/NCT02032368 Completed Guangdong Provincial People’s Hospital 2012-12-31
NCT02005770 Anesthesia and Circulating Tumor Cells in Breast Cancer https://ClinicalTrials.gov/show/NCT02005770 Completed University of Zurich 2018-04-30
NCT01975142 Validity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment. https://ClinicalTrials.gov/show/NCT01975142 Completed Institut Curie 2018-02-13
NCT02025413 Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture Method https://ClinicalTrials.gov/show/NCT02025413 Completed Duke University 2015-12-31
NCT01713699 Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases https://ClinicalTrials.gov/show/NCT01713699 Recruiting The Netherlands Cancer Institute 2020-04-30
NCT01640444 Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC) https://ClinicalTrials.gov/show/NCT01640444 Completed Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 2018-11-30
NCT01573494 Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic Melanoma https://ClinicalTrials.gov/show/NCT01573494 Completed Centre Hospitalier Universitaire de Nice 2013-11-30
NCT01548677 Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer https://ClinicalTrials.gov/show/NCT01548677 Completed European Organisation for Research and Treatment of Cancer - EORTC 2017-03-31
NCT04021459 Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery. https://ClinicalTrials.gov/show/NCT04021459 Recruiting University Hospital, Montpellier 2020-09-02
NCT03960021 Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin https://ClinicalTrials.gov/show/NCT03960021 Recruiting Institut Bergonié 2021-03-31
NCT03861598 Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells https://ClinicalTrials.gov/show/NCT03861598 Recruiting West Virginia University 2019-12-31
NCT03776591 Open D3 Right Hemicolectomy Compared to Laparoscopic CME for Right Sided Colon Cancer https://ClinicalTrials.gov/show/NCT03776591 Recruiting Haraldsplass Deaconess Hospital 2025-09-01
NCT03772496 Diagnostic Significance of CTCs in Patients With Thyroid Nodules (Circulating Tumor Cells) https://ClinicalTrials.gov/show/NCT03772496 Recruiting Cancer Institute and Hospital, Chinese Academy of Medical Sciences 2019-12-20
NCT03732339 CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial https://ClinicalTrials.gov/show/NCT03732339 Completed RenJi Hospital 2019-03-11
NCT03721133 Recurrent Predictive Power of Circulating Tumor Cell in Non Small Cell Lung Cancer Patients Who Receive Curative Resectionresection https://ClinicalTrials.gov/show/NCT03721133 Enrolling by invitation Chang Gung Memorial Hospital 2021-07-31
NCT03700541 Influence of Opioid Analgesia on Circulating Tumor Cells in Laparoscopic Colorectal Cancer Surgery https://ClinicalTrials.gov/show/NCT03700541 Recruiting The Institute of Molecular and Translational Medicine, Czech Republic 2021-01-31
NCT03700411 Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer Surgery https://ClinicalTrials.gov/show/NCT03700411 Recruiting The Institute of Molecular and Translational Medicine, Czech Republic 2021-01-31
NCT03481101 WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC https://ClinicalTrials.gov/show/NCT03481101 Recruiting Rigshospitalet, Denmark 2021-02-26
NCT03436329 Reduced Dissemination of Tumor Cells With Primary Ligation of the Vein in Patients With Lung Cancer https://ClinicalTrials.gov/show/NCT03436329 Active, not recruiting West China Hospital 2018-05-31
NCT01015625 Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer https://ClinicalTrials.gov/show/NCT01015625 Active, not recruiting Austrian Breast & Colorectal Cancer Study Group 2021-06-30
NCT02666612 Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer https://ClinicalTrials.gov/show/NCT02666612 Recruiting Gustave Roussy, Cancer Campus, Grand Paris 2023-08-31
NCT01349842 Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer https://ClinicalTrials.gov/show/NCT01349842 Completed Institut Curie 2016-01-31
NCT00429182 Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer https://ClinicalTrials.gov/show/NCT00429182 Completed M.D. Anderson Cancer Center 2012-02-29

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03381326 CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC. https://ClinicalTrials.gov/show/NCT03381326 Active, not recruiting Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori 2019-10-31
NCT03295591 Circulating Tumor Cells in mCRC for Liver Resection https://ClinicalTrials.gov/show/NCT03295591 Recruiting The University of Hong Kong 2019-11-30
NCT03162198 Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT03162198 Completed Institute of Liver and Biliary Sciences, India 2018-10-31
NCT03161821 Circulating Tumor Cells in Solid Tumors https://ClinicalTrials.gov/show/NCT03161821 Recruiting UNC Lineberger Comprehensive Cancer Center 2022-12-01
NCT03032913 Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC https://ClinicalTrials.gov/show/NCT03032913 Completed University Hospital, Bordeaux 2017-11-13
NCT03013868 CTCs and Novel Target Bio-marker Analysis for Prediction and Monitoring of Metastasis/Recurrence in Post-surgery Colorectal Cancer Patients Using MiSelect R Rare Cell System https://ClinicalTrials.gov/show/NCT03013868 Recruiting MiCareo Taiwan Co., Ltd. 2020-12-31
NCT02940977 Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique https://ClinicalTrials.gov/show/NCT02940977 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2019-03-30
NCT02904161 Detection of Circulating Tumor Cells in Peripheral Blood From Healthy Volunteers and Patients With Cancer https://ClinicalTrials.gov/show/NCT02904161 Completed MiCareo Taiwan Co., Ltd. 2016-11-30
NCT02904135 Collection of Circulating Tumor Cells From the Peripheral Blood of Metastatic Breast Cancer Patients https://ClinicalTrials.gov/show/NCT02904135 Completed MiCareo Taiwan Co., Ltd. 2016-12-31
NCT02874885 Circulating Tumor Cells in Patients With Rectal Cancer https://ClinicalTrials.gov/show/NCT02874885 Recruiting M.D. Anderson Cancer Center 2023-09-30
NCT02827344 PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02827344 Recruiting University Hospital, Toulouse 2019-10-31
NCT02812680 The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal Adenocarcinoma https://ClinicalTrials.gov/show/NCT02812680 Recruiting University Health Network, Toronto 2021-06-30
NCT02781025 Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease https://ClinicalTrials.gov/show/NCT02781025 Recruiting UNC Lineberger Comprehensive Cancer Center 2021-01-31
NCT02630615 Circulating Tumor Cells (CTC) in Lung Cancer https://ClinicalTrials.gov/show/NCT02630615 Recruiting Indiana University 2019-11-30
NCT02499458 Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer https://ClinicalTrials.gov/show/NCT02499458 Completed Lawson Health Research Institute 2018-12-31
NCT02450448 The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment https://ClinicalTrials.gov/show/NCT02450448 Completed Fuda Cancer Hospital, Guangzhou 2015-12-31
NCT02450435 The Detection of Circulating Tumor Cells (CTCs) in Patients With Prostatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment https://ClinicalTrials.gov/show/NCT02450435 Completed Fuda Cancer Hospital, Guangzhou 2015-12-31
NCT02450357 The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment https://ClinicalTrials.gov/show/NCT02450357 Completed Fuda Cancer Hospital, Guangzhou 2015-12-31
NCT02449837 Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy https://ClinicalTrials.gov/show/NCT02449837 Recruiting UNC Lineberger Comprehensive Cancer Center 2020-11-30
NCT02416635 The Detection of Circulating Tumor Cells (CTCs) in Patients With Liver Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment https://ClinicalTrials.gov/show/NCT02416635 Completed Fuda Cancer Hospital, Guangzhou 2015-12-31
NCT02412384 The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment https://ClinicalTrials.gov/show/NCT02412384 Completed Fuda Cancer Hospital, Guangzhou 2015-12-31
NCT02380196 The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02380196 Completed Abramson Cancer Center of the University of Pennsylvania 2019-12-31
NCT02370303 A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System https://ClinicalTrials.gov/show/NCT02370303 Completed Mayo Clinic 2016-07-09
NCT02345473 Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy https://ClinicalTrials.gov/show/NCT02345473 Completed Azienda Ospedaliero-Universitaria Consorziale 2014-10-31
NCT02150746 Circulating Tumor Cells in Operative Blood https://ClinicalTrials.gov/show/NCT02150746 Completed University of Florida 2016-02-29
NCT01299688 HER2 Circulating Tumor Cells in Gastric Cancer https://ClinicalTrials.gov/show/NCT01299688 Completed Samsung Medical Center 2013-03-11
NCT01961713 Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy https://ClinicalTrials.gov/show/NCT01961713 Recruiting Massachusetts General Hospital 2020-04-30
NCT01943500 Collection of Blood Specimens for Circulating Tumor Cell Analysis https://ClinicalTrials.gov/show/NCT01943500 Completed Viatar LLC 2014-01-28
NCT01830426 Circulating Tumor Cells in Non-Small Cell Lung Carcinoma https://ClinicalTrials.gov/show/NCT01830426 Completed Epic Sciences 2015-12-31
NCT01740804 Dynamic Circulating Tumor Cell (CTC) Changes During the Chemotherapy in NSCLC https://ClinicalTrials.gov/show/NCT01740804 Completed Guangdong Association of Clinical Trials 2016-04-30
NCT01734915 Detecting EGFR T790M Mutations From Circulating Tumor Cells https://ClinicalTrials.gov/show/NCT01734915 Completed Massachusetts General Hospital 2016-09-30
NCT01716065 Regional Anesthesia Versus General Anesthesia on Circulating Tumor Cells (CTC) https://ClinicalTrials.gov/show/NCT01716065 Completed Defense and Veterans Center for Integrative Pain Management 2013-05-31
NCT01701050 Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index https://ClinicalTrials.gov/show/NCT01701050 Completed Janssen Diagnostics, LLC 2016-11-10
NCT01558349 Circulating Tumor Cells and Melanoma: Comparing the EPISPOT and CellSearch Techniques https://ClinicalTrials.gov/show/NCT01558349 Completed Centre Hospitalier Universitaire de Nīmes 2017-06-27
NCT01528774 Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers https://ClinicalTrials.gov/show/NCT01528774 Completed Comprehensive Cancer Centers of Nevada 2016-06-30
NCT01322893 Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer https://ClinicalTrials.gov/show/NCT01322893 Completed Lund University Hospital 2016-06-30
NCT01322750 Circulating Tumor Cells (CTCs): A Potential Screening Test for Clinically Undetectable Breast Carcinoma https://ClinicalTrials.gov/show/NCT01322750 Recruiting Walter Reed Army Medical Center 2013-01-31
NCT04125667 Culture System for Isolating Circulating Tumor cells_2 https://ClinicalTrials.gov/show/NCT04125667 Recruiting National Taiwan University Hospital 2020-08-31
NCT04083547 Circulating Tumour Cells in Patients With Peritoneal Metastases https://ClinicalTrials.gov/show/NCT04083547 Recruiting Uppsala University 2019-10-01
NCT04065321 Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer https://ClinicalTrials.gov/show/NCT04065321 Recruiting Shengjing Hospital 2024-09-30
NCT04048512 Circulating Tumor Cells (CTC) Before and After Thoracic Resection With and Without Intraoperative Use of ExtraCorporeal Membrane Oxygenator(ECMO) or Cardio Pulmonary By Pass (CPB) https://ClinicalTrials.gov/show/NCT04048512 Recruiting European Institute of Oncology 2020-07-22
NCT03843450 Culture System for Isolating Circulating Tumor Cells https://ClinicalTrials.gov/show/NCT03843450 Recruiting National Taiwan University Hospital 2020-07-01
NCT03809403 Influence of the Surgical Technique Used for Colectomies on the Concentration of Circulating Tumor DNA and the Presence of Circulating Tumor Cells: Comparison of the “no Touch” Technic With Either First Clamping of the Mesenteric Vessels or First Mobilization of the Tumor Followed by Clamping. https://ClinicalTrials.gov/show/NCT03809403 Recruiting Assistance Publique - Hôpitaux de Paris 2019-08-31
NCT03744962 MSI in Circulatory DNA of Endometrial Cancer https://ClinicalTrials.gov/show/NCT03744962 Recruiting Peking Union Medical College Hospital 2020-12-23
NCT03655015 Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer https://ClinicalTrials.gov/show/NCT03655015 Recruiting The University of Texas Health Science Center at San Antonio 2020-09-30
NCT03488706 Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level https://ClinicalTrials.gov/show/NCT03488706 Recruiting CellMaxLife 2018-12-12
NCT03479099 Liquid Biopsy in Lung Cancer https://ClinicalTrials.gov/show/NCT03479099 Completed Samsung Medical Center 2019-03-11
NCT01173458 Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT01173458 Completed University of Kansas Medical Center 2012-11-30
NCT01173445 Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01173445 Completed University of Kansas Medical Center 2011-05-31
NCT01163305 PET-CT and Circulating Tumor Cells in Colorectal Cancer https://ClinicalTrials.gov/show/NCT01163305 Completed Chinese University of Hong Kong 2017-04-27
NCT01048918 Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast Cancer https://ClinicalTrials.gov/show/NCT01048918 Active, not recruiting City of Hope Medical Center 2020-08-31
NCT01022723 Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells https://ClinicalTrials.gov/show/NCT01022723 Recruiting National Cancer Centre, Singapore 2018-12-31
NCT03724500 Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03724500 Recruiting Chang Gung Memorial Hospital 2020-12-31
NCT01858805 Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer https://ClinicalTrials.gov/show/NCT01858805 Completed Universitätsklinikum Hamburg-Eppendorf 2014-04-30
NCT00829920 The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease https://ClinicalTrials.gov/show/NCT00829920 Completed University of Colorado, Denver 2012-11-30
NCT02450422 The Detection of Circulating Tumor Cells (CTCs) in Patients With Colorectal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment https://ClinicalTrials.gov/show/NCT02450422 Completed Fuda Cancer Hospital, Guangzhou 2015-12-31
NCT01800058 Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy https://ClinicalTrials.gov/show/NCT01800058 Completed Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 2018-12-21
NCT00571389 Isolation and Culture of Immune Cells and Circulating Tumor Cells From Peripheral Blood and Leukopaks https://ClinicalTrials.gov/show/NCT00571389 Recruiting BioCytics, Inc. 2019-01-31
NCT00568282 Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients https://ClinicalTrials.gov/show/NCT00568282 Active, not recruiting Stanford University 2017-03-08
NCT00495924 Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT00495924 Completed KU Leuven NA
NCT00493350 Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer https://ClinicalTrials.gov/show/NCT00493350 Completed M.D. Anderson Cancer Center 2007-12-31
NCT00351572 Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients https://ClinicalTrials.gov/show/NCT00351572 Completed AHS Cancer Control Alberta NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03156777 Application Value of CTCs Detection for Advanced Gastric Cancer Patients https://ClinicalTrials.gov/show/NCT03156777 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2018-12-31
NCT02974764 Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT02974764 Completed Johns Hopkins University 2018-12-31
NCT02973204 Circulating Tumor Cells and Tumor DNA in HCC and NET https://ClinicalTrials.gov/show/NCT02973204 Recruiting University of Aarhus 2019-10-31
NCT02406846 The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment. https://ClinicalTrials.gov/show/NCT02406846 Completed Fuda Cancer Hospital, Guangzhou 2015-12-31
NCT04254497 A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer https://ClinicalTrials.gov/show/NCT04254497 Completed Changi General Hospital 2019-08-27